Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMIZED trial
2025-521316-19-00Phase 4Authorised
- Sponsor
- Leiden University Medical Center
- Start
- Nov 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Lithiasis and Renal colic comparing ESPB with ropivacaine with Comparator (placebo/standard care) (2 arms). Primary endpoints: Pain intensity and interference at 24 hours and Hospitalizations and urologic interventions within 7 days. Planned start Nov 2025; status: authorised.
02
Drugs
ropivacaine
03
Conditions
LithiasisRenal colic
Beyond the preview
Go deeper on 2025-521316-19-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521316-19-00.